Tags
FDA
Latest Tag News
-
FDA Warns Public About Skin Cancer Creams As It May Kill Pets
By Meiwa Javellana | Jan 20, 2017 09:10 AM ESTFive dogs have been reported to have died because of the skin cancer creams. The Food and Drug Administraion has released a warning to ensure safety of use.
-
Implantable Cardiac Devices Threatened By Hackers, FDA Warns
By Angela Laguipo | Jan 12, 2017 09:00 AM ESTThe U.S. Food and Drug Administration (FDA) warned against implantable cardiac devices, which have been found to be susceptible to online hacking.
-
FDA Speeds Up Review Of Roche's Immunotherapy Drug Tecentriq For Bladder Cancer
By Angela Laguipo | Jan 10, 2017 10:20 AM ESTThe U.S. Food and Drug Administration (FDA) agreed to speed up the review of Roche's Tecentriq, the immunotherapy drug intended for metastatic urothelial carcinoma.
-
Kim Kardashian-Endorsed Morning Sickness Drug's Efficacy Questioned
By Angela Laguipo | Jan 06, 2017 09:00 AM ESTDiclegis, a drug used for decades to treat morning sickness, has been endorsed by Kim Kardashian in 2015. Now, doctors are questioning its efficacy.
-
Pfizer's Celebrex Is Not Exposing You to Cardiovascular Risks Than Other NSAIDs
By Bella Harshan | Nov 17, 2016 11:10 AM ESTCox-2 inhibitor, Celebrex, used as an arthritis drug, has been found to pose lower heart risk than its rivals.
-
FDA Orders Removal Of Certain Antibacterial Ingredients In Soaps; Know Why
By Jenia Cane | Sep 07, 2016 12:08 PM EDTThe United States Food and Drug Administration has ordered the removal of antibacterial ingredients in soaps.
-
Why the US Salt Consumption Needs to Be Monitored: FDA
By Mariel Peralta | Jun 10, 2016 06:23 AM EDTCDC director Thomas Frieden announced that US citizens have too much salt intake and this could pose a threat to their health.
-
Diarrhea Drug Overdose May Lead to Heart Problems: FDA
By Mariel Peralta | Jun 09, 2016 06:06 AM EDTOverdosing on the diarrhea drug Imodium to help stem opioid addiction can cause heart problems, the FDA said.
-
Why First Duchenne Muscular Dystrophy Drug Failed FDA Requirements
By Brian McNeill | Apr 27, 2016 04:20 AM EDTDuchenne Muscular Dystrophy is a serious case that plagues about 9,000 to 12,000 Americans (mostly boys) and a potential drug called eteplirsen could be the answer many have been waiting for.
-
Smokeless Tobacco And Cancer Link Found: Why FDA Hates Chews, Dips
By Chris Bale | Apr 21, 2016 06:09 AM EDTThe United States Food and Drug Administration (FDA) have highlighted the dangers of smokeless tobacco on its advertisements for the first time. Their goal is to educate the rural, white male teenagers who are usually the victims of this cancer causing habit.
-
FDA issues Black Box Warning for Bayer’s birth control implant Essure
By Cheri Cheng | Mar 01, 2016 11:44 AM ESTThe FDA has recommended Bayer AG to include a black box warning and to conduct a post-market safety study for its contraceptive product, Essure.
-
US Senate Selects Dr. Robert Califf As New FDA Commissioner
By Jenn Loro | Feb 26, 2016 10:50 AM ESTObama nominee Robert Califf has been recently confirmed as the new commissioner of FDA amid frustration over widespread painkiller abuse as well as his supposed links to big drug firms during his years as clinical researcher at Duke University.
-
Report Claims FDA most likely Underestimated Number of Fetal Deaths from Essure
By Cheri Cheng | Feb 18, 2016 10:40 AM ESTA new analysis is claiming that the FDA most likely underestimated the number of fetal deaths from Bayer's Essure.
-
HPV Increases Likelihood Of Head, Neck And Throat Cancer
By Mara Mayer | Jan 23, 2016 04:37 PM ESTNew study suggests that oral human papilloma virus (HPV) infection linked to HPV 16 increases the risk for head and neck cancer 22 times indicating a strong causal role in development of other cancers than was previously known.
-
Positive Findings May Lift FDA Hold On Zafgen’s Obesity Drug Trials
By Jenn Loro | Jan 22, 2016 08:57 AM ESTCrucial positive findings on Zafgen’s experimental obesity medication, beloranib, raises hopes on reversing FDA’s suspension of its drug approval bid following two deaths during the clinical trials.
